How the Pfizer building scare could push developers to rethink vertical conversion plans
Following the near collapse of the Pfizer building conversion project last week, the industry has grappled with the potential impacts of the alarming structural failure. Aside from the consequences for the project itself, such as construction delays and financing constraints, real estate players are also attempting to forecast the incident’s effect on other office-to-residential conversion bets in the city, as well as on the larger development landscape. Though the fallout is still taking shape, many expect the aftermath to bring new regulations or heightened enforcement of existing rules, moves that city agencies and members of the New York City Council […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

AI firm founded by three teenagers nearly triples NYC office footprint

Nobody wants Ziel Feldman’s penthouse

Contractor stacked demo-related fines at 24 sites pre-collapse

Tribeca Film Festival founders find happy ending with Dakota deal

Kushner, RFR face foreclosure at Dumbo Heights office campus

Affordable Housing, Lower Climate Risk: Is Cincinnati The Future?

6 Top Homeowner Trends For 2027, According To New Report

2026 Fall Home Decor Trends And Colors – Plus Home Maintenance Tips

The Root Of Housing Challenges: Too Many Risky Player Handoffs

Inside Bāzār, Designer Ryan Saghian’s New Retail Concept At Century Plaza Promenade


